| Cash and cash equivalents | 287.06K |
| Prepaid research supplies and expenses | |
| Total Current Assets | 375.91K |
| Equipment, furniture and fixtures, net | 80.92K |
| Intangibles, net | |
| Deferred income tax assets, net | |
| Security deposit | 55.77K |
| TOTAL ASSETS | 7.01M |
| Accounts payable | 144.87K |
| Accrued expenses | 316.29K |
| Line of credit | |
| Total Current Liabilities | 467.27K |
| Warrant liabilities | 319.55K |
| Grant payable | 0 |
| TOTAL LIABILITIES | 3.39M |
| Preferred stock, $0.01 par value, authorized 5,000,000 shares | |
| Common stock, $0.01 par value, authorized 250,000,000 shares, issued and outstanding 79,695,624 and 77,769,677, respectively | 204.96K |
| Capital in excess of par | 119.99M |
| Deficit accumulated during the development stage | |
| Total Stockholders' Equity | 3.63M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 7.01M |
| Preferred stock, $0.01 par value, authorized 5,000,000 shares | |
| Preferred stock | 4 |
| Preferred stock, $0.01 par value, authorized 5,000,000 shares | |
| Preferred stock | 2.35K |